US Patent Issued to Genentech on Sept. 9 for "Polymorphs and solid forms of (S)-2-2((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[fimidazo[1,2-d[1,4oxazepin-9- yl)amino)propanamide, and methods of production" (California Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,189, issued on Sept. 9, was assigned to Genentech Inc. (South San Francisco, Calif.).

"Polymorphs and solid forms of (S)-2-2((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[fimidazo[1,2-d[1,4oxazepin-9- yl)amino)propanamide, and methods of production" was invented by Paroma Chakravarty (San Francisco), Chong Han (Foster City, Calif.), Sean M. Kelly (San Mateo, Calif.), Karthik Nagapudi (San Ramon, Calif.) and Scott Savage (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Crystalline polymorph forms of(S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino...